Harper Molly bought CPRX
December 12, 2025 · Form 4 insider transaction
Harper Molly bought 20,000 shares of Catalyst Pharmaceuticals Inc at $5.78 per share, a transaction worth $115.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$5.78
Total value
$115.6K
InsiderHarper Molly
Role—
SecurityCommon stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after29,106
OwnershipDirect
10b5-1 planNo
AmendedNo